Latest news for IMCD (OTC:IMCDY) Stock

IMCD NV manufactures and sells a variety of chemicals and food ingredients. The firm's product portfolio consists of two categories: Life Science consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care and I&I, and The Industrial segment contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments; EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment.

IMCD NV

JP Morgan analyst Christopher Horvers maintains Home Depot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) with a Overweight and raises the price target from $450 to $475.

News

Price Target

Analyst Ratings

JP Morgan Maintains Overweight on Home Depot, Raises Price Target to $475

B of A Securities analyst Ross Gilardi maintains Oshkosh (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSK#NYSE">OSK</a>) with a Underperform and raises the price target from $95 to $110.

B of A Securities Maintains Underperform on Oshkosh, Raises Price Target to $110

Needham analyst Ami Fadia reiterates Praxis Precision Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRAX#NASDAQ">PRAX</a>) with a Buy and maintains $150 price target.

Reiteration

PRAX

Needham Reiterates Buy on Praxis Precision Medicine, Maintains $150 Price Target

PLYA

Trading Halt: Halted at 6:55:00 a.m. ET - Trading Halt: Halt News Pending

U.S. stock futures rose on Monday after Friday&#8217;s sharp fall as investors digested the tariff updates and earnings reports. All four benchmark indices were trading higher.
Investors will look out for inflation data slated to be released on Wednesday this week.
The week&#8217;s corporate earnings calendar features a mix of companies across various sectors. Consumer-focused giants like McDonald&#8217;s Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>), Coca-Cola Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), and Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) are set to report their financial results, alongside drugmakers Moderna Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) and Vertex Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>).
In the tech world, investors will be watching for updates from Cisco Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) and Applied Materials Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>), as well as platforms like Robinhood Markets Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) and Coinbase Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>).
The 10-year Treasury yield stood at 4.49%, while the two-year yield was at 4.28%. According to the CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>, there is a 91.5% chance that the Federal Reserve will keep interest rates unchanged for the March meeting.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.61%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.38%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.27%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.32%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) both experienced positive premarket trading on Monday. SPY rose 0.47% to $603.57, and QQQ advanced 0.68% to $526.46, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
All sectors of the S&amp;P 500 closed <a href="https://www.benzinga.com/25/02/43585561/dow-dips-over-400-points-following-tariffs-threat-investor-sentiment-declines-fear-greed-index-in-fear-zone">lower</a> on Friday, with communication services, consumer discretionary, and materials leading the losses. President Donald Trump announced that &#8216;reciprocal tariffs&#8217; would take effect next week, further escalating trade tensions.
Investor sentiment was impacted by a mixed January jobs report, heightened inflation expectations, and concerns over trade tariffs. The University of Michigan's consumer sentiment survey showed a sharp rise in inflation expectations, with the one-year outlook reaching 4.3%, its highest since November 2023.
Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) reported stronger-than-expected fourth-quarter earnings, but its first-quarter sales guidance fell short of market expectations, forecasting net sales between $151 billion and $155.5 billion, below the $158.5 billion estimate.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-1.36%</td>
<td>19,523.40</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.95%</td>
<td>6,025.99</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.99%</td>
<td>44,303.40</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-1.19%</td>
<td>2,279.71</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
After Friday's sharp decline, Ryan Detrick, chief market strategist at Carson Research, highlighted that Mondays and Fridays have been weak for stocks so far in 2025.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Monday and Friday have been quite bad for stocks so far in 2025. The other three days have been solid. <a href="https://t.co/KMO8EiTWCR">pic.twitter.com/KMO8EiTWCR</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1888605947322417213?ref_src=twsrc%5Etfw">February 9, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Peter Mallouk, CEO of CPI Wealth, stated that &#8216;Cash is NOT King,&#8217; referencing a graphic showing that the cost of holding cash has risen over 2,000% in the past 30 years.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Over one-year periods, the average cost of holding cash has been roughly 8%. But over 30-year periods, this grows to more than 2,000%. Cash is NOT King. <a href="https://t.co/0dXlfOkGCD">pic.twitter.com/0dXlfOkGCD</a>
&mdash; Peter Mallouk (@PeterMallouk) <a href="https://twitter.com/PeterMallouk/status/1887864895468617828?ref_src=twsrc%5Etfw">February 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
According to the data underscored by Adam Turnquist, the chief technical strategist for LPL Financial, bullish sentiment has been gradually declining after remaining above average for most of last year.
"Currently, only about one-third of investors express a bullish outlook on stocks over the next six months, down approximately 8% from the previous week," he said.
However, Turnquist added that while sentiment is clearly not a science and usually follows price, the current degree of bearish sentiment could be considered a contrarian signal, "suggesting that the recent dip in stocks may have reached its low point."
See Also:&nbsp;<a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures</a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on this week:
<ul>
<li>There is no data scheduled to be released on Monday</li>
</ul>
<ul>
<li>On Tuesday, January&#8217;s NFIB optimism index data will be released at 6:00 a.m., ET.</li>
</ul>
<ul>
<li>Cleveland Fed President Beth Hammack will speak at 8:50 a.m., ET.</li>
</ul>
<ul>
<li>Federal Reserve Chair Jerome Powell will begin his testimony to Congress at 10:00 a.m. ET.</li>
</ul>
<ul>
<li>San Francisco Fed President Mary C Daly will speak at 10:20 a.m., and New York Fed President John C Williams and Fed Governor Michelle Bowman will speak at 3:30 p.m., ET.</li>
</ul>
<ul>
<li>On Wednesday, core and headline consumer price index data for January will be announced at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>Fed Chairman Jerome Powell&#8217;s testimony to Congress continues at 10:00 a.m., ET.</li>
</ul>
<ul>
<li>Atlanta Fed President Raphael Bostic will speak at 2:00 p.m. and New York Fed President Williams will speak again at 3:30 p.m., ET.</li>
</ul>
<ul>
<li>January&#8217;s monthly U.S. federal budget data will be out by 2:00 p.m., ET.</li>
</ul>
<ul>
<li>Fed Governor Christopher Waller will be speaking at 5:05 p.m., ET.</li>
</ul>
<ul>
<li>On Thursday, initial jobless claims till Feb. 8 will be out at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>The headline and core producer price index data for January will be released at 8:30 a.m., ET as well.</li>
</ul>
<ul>
<li>On Friday, January&#8217;s import price index data and U.S. retail sales will be out by 8:30 a.m., ET.</li>
</ul>
<ul>
<li>January&#8217;s industrial production data and capacity utilization data will be released at 9:15 a.m., ET.</li>
</ul>
<ul>
<li>Business inventories data for December will be announced at 10:00 a.m., ET.</li>
</ul>
<ul>
<li>Dallas Fed President Lorie Logan will speak at 3:00 p.m., ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>McDonald&#8217;s Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) was up 0.09% in premarket on Monday ahead of its earnings, which will be released before the opening bell. Analysts expect it to report quarterly earnings of $2.84 per share on revenue of $6.44 billion.</li>
</ul>
<ul>
<li>ON Semiconductor Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) fell 2.15% as Wall Street expects it to report quarterly earnings of 97 cents per share on revenue of $1.76 billion before the opening bell.</li>
</ul>
<ul>
<li>Rockwell Automation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) slipped 0.58% ahead of its earnings, which will be released before the opening bell. Analysts expect it to report quarterly earnings of $1.59 per share on revenue of $1.88 billion.</li>
</ul>
<ul>
<li>Vertex Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) rose 0.36% as Wall Street expects it to report quarterly earnings of $4.03 per share on revenue of $2.78 billion after the closing bell.</li>
</ul>
<ul>
<li>Hims &amp; Hers Health Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) was up 3.20% despite being under scrutiny for its weight loss drug advertisement during the Super Bowl. Two U.S. senators expressed concerns over misleading information as the ad omitted any safety or side effect information.</li>
</ul>
<ul>
<li>MGO Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGOL#NASDAQ">MGOL</a>) was up 64.55% as the SEC approved its proposed business combination with Heidmar Inc.</li>
</ul>
<ul>
<li>T-Mobile Us Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) was up 3.98% after its satellite-based mobile network in the U.S. went live which automatically connects phones in areas without cellular coverage.</li>
</ul>
<ul>
<li>BP Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) was up 6.04% after reports claiming that Paul Singer&#8216;s hedge fund Elliott Management has built a stake in the oil major.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 1.17% to hover around $71.83 per barrel.
The gold spot index rose 1.41% to $2,900.64 per ounce after hitting a fresh record high of $2,906.2 today.. The Dollar Index was up 0.15% at 108.201 level.
Asian markets were mixed on Monday. Australia's ASX 200, South Korea's Kospi, and India's S&amp;P BSE Sensex index fell. Whereas, China's CSI 300, Hong Kong's Hang Seng, and Japan's Nikkei 225 index advanced. European markets were mostly higher in trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43586493/jpmorgan-bofa-equifax-honda-block-and-many-more-may-get-relief-after-cfpb-dissolution-as-director-vought-halts-activities-maryland-senator-says-will-ensure-the-body-continues-to-fight-for-consumers">JPMorgan, BofA, Equifax, And Others May Get Relief After CFPB Dissolution: Maryland Senator Says He Will Ensure It Continues To &#8216;Fight For Consumers&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Analyst Color

Earnings

Government

Futures

Economics

Federal Reserve

Pre-Market Outlook

Markets

ETFs

AMAT

AMZN

COIN

CSCO

Hims & Hers Health, Inc. Class A Common Stock

HIMS

HOOD

MGOL

MRNA

SHOP

TMUS

VRTX

US Stocks To Open On A Positive Note After A String Of Bad Mondays: Recent Dip Has 'Reached Its Low Point,' Says Technical Analyst

JP Morgan analyst Arun Jayaram initiates coverage on Flowco Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOC#NYSE">FLOC</a>) with a Overweight rating and announces Price Target of $32.

Initiation

FLOC

JP Morgan Initiates Coverage On Flowco Holdings with Overweight Rating, Announces Price Target of $32

HC Wainwright &amp; Co. analyst Matthew Caufield reiterates 4D Molecular Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDMT#NASDAQ">FDMT</a>) with a Buy and maintains $36 price target.

FDMT

HC Wainwright & Co. Reiterates Buy on 4D Molecular Therapeutics, Maintains $36 Price Target

Jefferies analyst Lloyd Byrne initiates coverage on Flowco Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOC#NYSE">FLOC</a>) with a Buy rating and announces Price Target of $35.

Jefferies Initiates Coverage On Flowco Holdings with Buy Rating, Announces Price Target of $35

Guidance

Spirit AeroSystems Expects Future Free Cash Flow Usage For Q1, Q2 2025  To Be $650M - $700M

Needham analyst Joseph Stringer maintains Pliant Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) with a Buy and lowers the price target from $38 to $10.

PLRX

Needham Maintains Buy on Pliant Therapeutics, Lowers Price Target to $10

Needham analyst Ryan Koontz reiterates Viasat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>) with a Buy and maintains $19 price target.

VSAT

Needham Reiterates Buy on Viasat, Maintains $19 Price Target

Up to €15 billion of data center investment will be led by Brookfield's portfolio company, Data4, one of Europe's largest data center developers, headquartered in Paris.&nbsp;
Data4 has existing plans to build over 500 MW of data center capacity located across several regions in France, with an ambition to triple that by 2030 as part of today's announcement. With this, France is projected to be the single largest market for Data4 in Europe.

Brookfield Asset Management Reveals €20B Infrastructure Investment Program To Support  Deployment Of AI Infrastructure In France

DA Davidson analyst Brian Holland maintains Hershey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>) with a Neutral and lowers the price target from $164 to $149.

DA Davidson Maintains Neutral on Hershey, Lowers Price Target to $149

Management

Cemex CEO Fernando González Decides To Retire; Jaime Muguiro Appointed As New CEO, Effective April 1, 2025

Spirit AeroSystems Expects Continued Operational Environment And Higher Delivery Rates To Drive Better Results In 2025

HC Wainwright &amp; Co. analyst Andrew Fein reiterates Corbus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) with a Buy and lowers the price target from $80 to $75.

CRBP

HC Wainwright & Co. Reiterates Buy on Corbus Pharmaceuticals, Lowers Price Target to $75

Canaccord Genuity analyst Brian McNamara maintains Newell Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) with a Buy and lowers the price target from $15 to $14.

Canaccord Genuity Maintains Buy on Newell Brands, Lowers Price Target to $14

Revenue decreased from the fourth quarter of 2023, primarily due to the impacts from the Boeing Memorandum of Agreement (MOA) executed in October&nbsp;2023 recognized in the fourth quarter of 2023, including favorable pricing adjustments on the Boeing 787 program and the reversal of the potential claim related to the Boeing 737 vertical fin attach fittings issue, partially offset by higher Defense and Space revenues in the fourth quarter of 2024.&nbsp;
Overall deliveries increased during the fourth quarter of 2024 compared to the same period of 2023, including higher Boeing 737 deliveries.
Gross loss was recognized in the fourth quarter of 2024 compared to gross profit for the same period of 2023. The operating income recognized in the fourth quarter of 2023 included the favorable impact of the Boeing MOA executed in October&nbsp;2023 to the Boeing 787 program, including favorable change in estimates as well as a material right obligation liability reversal.

Spirit AeroSystems Says Merger With Boeing On Track To Close In Mid-2025

Spirit AeroSystems Q4 Preliminary Net Revenues $1.662B Vs $1.813B Last Year; Est $1.614B

HC Wainwright &amp; Co. analyst Ed Arce downgrades Pliant Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) from Buy to Neutral.

Comments

IMCD

News

Latest news for IMCD (OTC:IMCDY) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga